OUR PIPELINE

BioInvent has two active projects in clinical development.

 


In addition, BioInvent has a number of research stage projects that we consider promising; especially in the field of immuno-oncology.

READ MORE

Business Focus

BioInvent is generating value for shareholders by employing its antibody and cancer biology expertise to identify antibodies with novel mechanisms-of-action and novel oncology targets. The Company employs this approach to generate therapeutic immuno-modulating antibodies that can be developed for a broad range of cancer indications. The Company plans to bring these antibodies to the clinic through its own resources and together with partners.

READ MORE

Press Releases

MEET US

Sep 25-28, 2017, BioProcess International, Boston, USA

Sep 26-27, 2017, BioPharm America, Boston, USA

 

SCIENTIFIC ADVISORY BOARD ESTABLISHED
>>READ MORE

SEK